LIVE
Innovating the partnering future Monday, 26 October 17:30 - 18:30 CET
Day in the life of experienced dealmakers Wednesday, 28 October, 16:00 - 17:00 CET
COVID-19 therapeutics: Modality, efficacy and implications for access Thursday, 29 October, 17:00 - 18:00 CET
LIVE SESSIONS
EIT Health Innostars Award Monday, 26 October, 14:30 - 16:30 CET
EIT Health Headstart : COVID-19 focus Wednesday, 28 October, 14:00-14:30 CET
EIT Health Headstart : Cohort A Thursday, 29 October, 11:00-12:00 CET
EIT Health Headstart : Cohort B Thursday, 29 October 15:30-16:15 CET
What has COVID taught us so far? Tuesday, 27 October, 14:00 - 14:30 CET
Startup Slam sponsored by Johnson & Johnson Innovation Tuesday, 27 October, 15:00 - 16:00 CET
Live sessions may only be seen at the time listed on the partneringONE agenda
View more session topics
Log in to partneringONE
BIO-Europe Digital 2020 Networking: Long-lasting partnerships are like happy marriages Monday, 26 October 17:00 - 17:30 CET Thursday, 29 October 10:00 - 10:30 CET
Fireside chat screening with President of Novartis Institute of Biomedical Research (NIBR) and Live Q&A with Novartis Partnering Wednesday, 28 October 15:00 - 15:30 CET
Live Q&A with AGC Wednesday, 28 October 17:00 - 17:30 CET
ON-DEMAND SESSIONS
Anatomy of a deal: Amgen and Neuvolution
The future of biotech investment
Dealmaking in a digital environment
In conversation with:
Martin Crook and Brian Cook
Graziano Seghezzi
Marianne De Backer
Husseini Manji
Emergence of novel therapeutic modalities in neurodegeneration
Next directions in oncology
New tools to conquer chronic kidney disease
The repercussions of manufacturing requirements on cell and gene therapy dealmakings
Collaboration Close up: Global Grassroots Innovation at Boehringer Ingelheim
What a pandemic has taught us about digital health
Effective and efficient clinical trial strategies
Rare Diseases, patient data, and collaboration
Health Equity: Addressing Health Disparities During Therapeutic Development
Cross-Border Partnering between Europe, US & China
Regulatory considerations for microbiome based therapeutics
Commercialization opportunities within the human microbiome industry
Specializing and investing in the microbiome space
Watercooler Networking Grab a coffee and chat your peers! Join a conversation
Strava Activity Group Have you been active today? Work out with other attendees Join group